Novel Biomarkers in Eye Diseases

A special issue of Cells (ISSN 2073-4409). This special issue belongs to the section "Cellular Pathology".

Deadline for manuscript submissions: 10 February 2025 | Viewed by 34

Special Issue Editor


E-Mail Website
Guest Editor
Research and Development Laboratory for Biochemical, Molecular and Cellular Applications in Ophthalmological Sciences, Research Laboratories in Ophthalmology, IRCCS-Fondazione Bietti, 00184 Rome, Italy
Interests: neuromediators; ocular diseases; biomarkers; epigenetics; genetic variants
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

This Special Issue will explore biomarkers in eye diseases and their usefulness as indicators of pathological processes (diagnosis) or pharmacologic responses to a therapeutic intervention (precision medicine). Although the relevance of biomarkers in differential diagnosis is indisputable, the debate around the usefulness of eye biomarkers in ophthalmological practice is intensifying. Most biomarkers are found through expansive explorative studies on eye tissues and ocular fluids collected in the clinic and/or during surgery. Some biomarkers have been identified as key mediators of ocular inflammation, while others have been related to matrix remodeling, profibrogenesis, and angiogenesis/vasculogenesis. The concept of the eye as a mirror of the brain or gut has increased the interest in the utilization of tear biomarkers as indicators in the early diagnosis of diseases linked to the brain–gut–eye axis.

Tears, as well as aqueous, vitreous, and even vitreal reflux, represent a good biological matrix. Biomarker profiling has been reported in dry eye, eye infections, vitreoretinal diseases, microvascular eye diseases, diabetic retinopathies, intravitreal treatments, neurodegenerative and metabolic eye disorders, and eye tumors. However, full knowledge of biomarkers’ interplay with the microenvironment is still necessary in the case of individualized therapy (intravitreal injections).

We welcome original research and review articles covering any aspect of eye biomarkers detected using different biological matrix and devices, conventional tests, array chips, and next-generation microfluidic chips. Studies into the latest developments in how eye biomarkers can be exploited for the development of new targeted therapies or for patient follow-up will be considered. The aim will be to select, from a wide cluster of mediators, major actors in the development of new alternative strategies in the field of ophthalmology.

Dr. Alessandra Micera
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • biomarkers
  • tears
  • ocular surface
  • retina
  • ocular fluids
  • inflammation
  • neuromodulation
  • parainflammation
  • omics
  • lab-on-chip

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers

This special issue is now open for submission.
Back to TopTop